Fmoc-1-amino-4,7,10-trioxa-13-tridecanamine hydrochloride, 99.0%, 1g

"[S(R)]-N-((1S)-(Adamantan-1-yl)(5-(diphenylphosphanyl)-9,9-dimethyl-9H- xanthen-4-yl)methyl)-2-methyl-2-propanesulfinamide", 95%, 50mg

methyl [4-(chlorosulfonyl)phenyl]carbamate, 95.0%, 500mg

3,4-Dichlorobenzylamine, 99.00%, 5g

1-[2-(4-Fluorophenoxy)ethyl]-1H-benzoimidazol-2-ylamine, 97%, 1g

1-(4-BROMOPHENYL)CYCLOPROPANECARBOXAMIDE, 95.0%, 500mg

(1-(tert-Butoxycarbonyl)-3,5-dimethyl-1H-pyrazol-4-yl)boronic acid, 97.0%, 1g

8-tert-butyl-4-[2-(4-methoxyphenyl)acetyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

1-(3-methylbutyl)-4-nitro-1H-pyrazole, 95.0%, 1g

2,2,2-Trifluoroacetic acid compound with 7-azaspiro[3.5]nonane-2-carboxylic acid (1:1), 98%, 1g

tert-Butyl ((1-(hydroxymethyl)cyclopropyl)methyl)carbamate, 95.0%, 100mg

2,2,3,3,8,8,9,9-Octamethyl-4,7-dioxa-3,8-disiladecane, 95%, 25g

(3R,4R)-tert-Butyl 4-(aminomethyl)-3-hydroxypiperidine-1-carboxylate, 95.0%, 100mg